Author:
Ganser Gerd,Tenbrock Klaus,Minden Kirsten
Publisher
Springer Berlin Heidelberg
Reference83 articles.
1. AWMF Leitlinie Nr. 029/006 „Intraartikuläre Punktionen und Injektionen: Hygienemaßnahmen“. http://www.awmf.org/leitlinien/detail/II/029-006.html
2. Becker I, Horneff G (2017) Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibition and disease activity in the German biologics in pediatric rheumatology registry. Arthritis Care Res (Hoboken) 69(4):552–560
3. Bertamino M, Rossi F, Pistorio A, Lucigrai G, Valle M, Viola S, Magni-Manzoni S, Malattia C, Martini A, Ravelli A (2010) Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis. J Rheumatol 37:432–439
4. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482
5. Bolt IB, Cannizzaro E, Seger R, Saurenmann RK (2008) Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 35:703–706